Developmental analysis of the cytomegalovirus enhancer in transgenic animals

被引:61
作者
Baskar, JF
Smith, PP
Ciment, GS
Hoffmann, S
Tucker, C
Tenney, DJ
ColbergPoley, AM
Nelson, JA
Ghazal, P
机构
[1] Scripps Res Inst, RES INST, DEPT IMMUNOL, DIV VIROL R307B, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, RES INST, DEPT NEUROPHARMACOL, DIV VIROL R307B, LA JOLLA, CA 92037 USA
[3] OREGON HLTH SCI UNIV, DEPT MOLEC MICROBIOL & IMMUNOL, PORTLAND, OR 97201 USA
[4] OREGON HLTH SCI UNIV, DEPT ANIM CARE, PORTLAND, OR 97201 USA
[5] OREGON HLTH SCI UNIV, DEPT CELL BIOL & ANAT, PORTLAND, OR 97201 USA
[6] BRISTOL MYERS SQUIBB CO, WALLINGFORD, CT 06492 USA
[7] CHILDRENS NATL MED CTR, WASHINGTON, DC 20010 USA
关键词
D O I
10.1128/JVI.70.5.3215-3226.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The major immediate-early promoter (MIEP) of human cytomegalovirus (HCMV) constitutes a primary genetic switch for viral activation. In this study, regulation of the enhancer-containing segment (nucleotides -670 to +54) of the HCMV MIEP attached to the lacZ reporter gene was examined in the developing embryos of transgenic mice to identify temporal and tissue-specific expression. We find that the transgene reporter is first detected as a dorsal stripe of expression in the neural folds of embryos at day 8.5 postcoitum (p.c.). A broad expression pattern is exhibited in embryos at day 9.5 p.c. This pattern becomes more restricted by day 10.5 p.c. as organogenesis progresses. By day 14.5 p.c., prominent expression is observed in a subpopulation of central nervous system cells and spinal ganglia, endothelial cells, muscle, shin, thyroid, parathyroid, kidney, lung, liver, and gut cells, and the pancreas and submandibular and pituitary glands. This distribution pattern is discussed in relation to human congenital HCMV infection. These results suggest that the transcriptional activity of the HCMV MIEP may determine in part, the ability of the virus to specifically target developing fetal tissues in utero.
引用
收藏
页码:3215 / 3226
页数:12
相关论文
共 39 条
[1]   RETINOID ACTIVATION OF RETINOIC ACID RECEPTORS BUT NOT OF RETINOID-X RECEPTORS PROMOTES CELLULAR-DIFFERENTIATION AND REPLICATION OF HUMAN CYTOMEGALOVIRUS IN EMBRYONAL CELLS [J].
ANGULO, A ;
SUTO, C ;
BOEHM, MF ;
HEYMAN, RA ;
GHAZAL, P .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3831-3837
[2]   INFECTION OF MOUSE ECTOPLACENTAL CONE CELLS WITH MURINE CYTOMEGALO-VIRUS [J].
BASKAR, JF ;
HUANG, ES .
JOURNAL OF GENERAL VIROLOGY, 1981, 54 (JUN) :415-420
[3]   The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice [J].
Baskar, JF ;
Smith, PP ;
Nilaver, G ;
Jupp, RA ;
Hoffmann, S ;
Peffer, NJ ;
Tenney, DJ ;
ColbergPoley, AM ;
Ghazal, P ;
Nelson, JA .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3207-3214
[4]   DEMONSTRATION OF DEVELOPMENTAL ANOMALIES IN MOUSE FETUSES BY TRANSFER OF MURINE CYTOMEGALOVIRUS DNA-INJECTED EGGS TO SURROGATE MOTHERS [J].
BASKAR, JF ;
FURNARI, B ;
HUANG, ES .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (06) :1288-1295
[5]   CUTANEOUS VESICLES IN CONGENITAL CYTOMEGALOVIRUS-INFECTION [J].
BLATT, J ;
KASTNER, O ;
HODES, DS .
JOURNAL OF PEDIATRICS, 1978, 92 (03) :509-509
[6]   THE PALINDROMIC SERIES-I REPEATS IN THE SIMIAN CYTOMEGALO-VIRUS MAJOR IMMEDIATE-EARLY PROMOTER BEHAVE AS BOTH STRONG BASAL ENHANCERS AND CYCLIC-AMP RESPONSE ELEMENTS [J].
CHANG, YN ;
CRAWFORD, S ;
STALL, J ;
RAWLINS, DR ;
JEANG, KT ;
HAYWARD, GS .
JOURNAL OF VIROLOGY, 1990, 64 (01) :264-277
[7]   MICROGYRIA AND CYTOMEGALIC INCLUSION DISEASE IN INFANCY [J].
CROME, L ;
FRANCE, NE .
JOURNAL OF CLINICAL PATHOLOGY, 1959, 12 (05) :427-434
[8]   CONTRIBUTIONS OF PLACODAL AND NEURAL CREST CELLS TO AVIAN CRANIAL PERIPHERAL GANGLIA [J].
DAMICOMARTEL, A ;
NODEN, DM .
AMERICAN JOURNAL OF ANATOMY, 1983, 166 (04) :445-468
[9]   PRENATAL CYTOMEGALOVIRUS DISEASE AND CEREBRAL MICROGYRIA - EVIDENCE FOR PERFUSION FAILURE, NOT DISTURBANCE OF HISTOGENESIS, AS THE MAJOR CAUSE OF FETAL CYTOMEGALOVIRUS ENCEPHALOPATHY [J].
DIAS, MJM ;
HARMANTVANRIJCKEVORSEL, G ;
LANDRIEU, P ;
LYON, G .
NEUROPEDIATRICS, 1984, 15 (01) :18-24
[10]  
DOLLE P, 1990, DEVELOPMENT, V110, P1133